Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73689 |
Daclizumab
Ro 24-7375,Zenapax |
IL Receptor | Immunology/Inflammation |
Daclizumab (Zenapax)为人源化单抗,能特异性地抑制IL-2R-HA的α亚单位。Daclizumab (Zenapax)能通过与CD25的特异性结合而抑制IL-2和IL-2R-HA的结合。Daclizumab (Zenapax)研究多发性硬化症 。 |